TABLE 1.
Baseline Characteristics (N = 138)
| Characteristic | VR (N = 44) |
Petrolatum (N = 47) |
No Treatment (N = 47) |
|---|---|---|---|
| Age, mean ± SD, y | 5.8±2.9 | 5.8±2.7 | 5.8±2.9 |
| Gender, n (%) | |||
| Female | 21 (47.7) | 23 (48.9) | 27 (57.4) |
| Male | 23 (52.3) | 24 (51.1) | 20 (42.6) |
| Race/ethnicity, n (%) | |||
| White | 41 (93.2) | 40 (85.1) | 35 (74.5) |
| Black | 0 (0.0) | 1 (2.1) | 4 (8.5) |
| Hispanic | 3 (6.8) | 2 (4.3) | 1 (2.1) |
| Asian | 0 (0.0) | 2 (4.3) | 3 (6.4) |
| >1 race/ethnicity | 0 (0.0) | 2 (4.3) | 2 (4.3) |
| Other | 0 (0.0) | 0 (0.0) | 2 (4.3) |
| Duration of cough, mean ± SD, d | 4.3±1.6 | 4.1±1.4 | 4.4±1.5 |
| Duration of congestion, mean ± SD, d | 4.1±1.5 | 4.2±1.6 | 4.2±1.6 |
| Cough frequency score, mean ± SD | 5.6±1.3 | 5.1±1.2 | 5.3±1.2 |
| Cough severity score, mean ± SD | 5.1±1.3 | 5.0±1.4 | 5.0±1.2 |
| Congestion severity score, mean ± SD | 5.0±1.3 | 4.9±1.0 | 4.9±1.1 |
| Rhinorrhea severity score, mean ± SD | 3.6±1.8 | 3.4±1.8 | 3.4±1.6 |
| Effect on child ability to sleep score, mean ± SD | 5.1±1.6 | 5.3±1.5 | 5.2±1.5 |
| Effect on parent ability to sleep score, mean ± SD | 4.9±1.9 | 4.9±1.7 | 5.0±2.1 |
| Combined symptom score, mean ± SD | 29.1±6.4 | 28.5±5.9 | 28.8±5.7 |
No significant difference between treatment groups exists for any baseline characteristic.